# Celia Hart

> Celia Hart is a Series A investor at Supernova Invest backing Medical Device and Health Care. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Supernova Invest](https://shizune.co/investors/profile/supernova-invest)
- Location: Grenoble, France
- Total investments: 4
- Last investment: Dec 2023
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/hartcelia/

Celia Hart is a Series A investor at Supernova Invest in Grenoble focused on Medical Device and Health Care. Celia Hart - Partner @ Supernova Invest

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 3 | 75% |
| Health Care | 2 | 50% |
| Therapeutics | 1 | 25% |
| Biotechnology | 1 | 25% |
| Manufacturing | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Series B | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CarThera | CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reachthe brain. | $4.8M | Series B | Dec 11, 2023 |  |
| CarThera | CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reachthe brain. | $41.1M | Series B | Jun 27, 2023 |  |
| Cairdac | Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation. | $18.8M | Series A | Mar 31, 2022 |  |
| AcuSurgical | AcuSurgical is a startup developing a robot for vitreo-retinal surgery. | $7M | Series A | Feb 18, 2021 |  |

4 of 4 investments shown.

## Co-investors
- [Mérieux Equity Partners](https://shizune.co/investors/profile/merieux-equity-partners) — VC Fund, 2 deals together
- [Mérieux Equity Partners](https://shizune.co/investors/profile/m%C3%A9rieux-equity-partners) — VC Fund, 2 deals together
- [BOUSCAS](https://shizune.co/investors/profile/bouscas) — VC Fund, 1 deal together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 1 deal together
- [Carvest Crédit Agricole Régions Investissement](https://shizune.co/investors/profile/crdit-agricole-rgions-investissement) — VC Fund, 1 deal together
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 1 deal together

## About Supernova Invest

VC Fund · Paris, France

Supernova Invest is a European multi-stage VC firm with currently €800m AUM. Our team provides unparalleled expertise and patient capital in the fields of Digital, Industrial Technologies, Healthcare and Cleantech to support high-growth, deeptech start-ups and scale them globally. We support disruptive tech companies such as Soitec, Alice &Bob, Gleamer, UnitySC, Unseenlabs, ANYbotics or Loft Orbital. The Supernova team exited +25 companies through top IPO and M&A deals.

5 contacts available at Supernova Invest.

| Name | Title | Profile |
| --- | --- | --- |
| Etienne Moreau | DeepTech Partner | https://shizune.co/investors/profile/etienne-moreau |
| Michaël Thomas | Partner | https://shizune.co/investors/profile/micha%C3%ABl-thomas |
| Celia Hart | Partner | https://shizune.co/investors/profile/celia-hart |
| Claude-Sebastien Lerbourg | Investment Director | https://shizune.co/investors/profile/claude-sebastien-lerbourg |
| Gregoire Viot | CFO | https://shizune.co/investors/profile/gregoire-viot-312b |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Celia Hart invest in?

Celia Hart invests primarily in Medical Device, Health Care and Therapeutics startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Celia Hart last invest?

The most recent investment recorded for Celia Hart closed in Dec 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co